68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in Malignant Peritoneal Mesothelioma

Cihan Gündoğan1, Yunus Güzel1, Halil Kömek1

  • 1From the Departments of Nuclear Medicine.

Insights

This study highlights 68Ga-FAPI-04 PET/CT as a promising tool for diagnosing peritoneal mesothelioma. This imaging technique effectively identified tumor infiltration where 18F-FDG PET/CT was less conclusive, aiding in patient diagnosis.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiopharmaceuticals

Background:

  • Peritoneal mesothelioma diagnosis can be challenging, often requiring invasive procedures.
  • 18F-FDG PET/CT is a standard imaging modality but may show limited uptake in some peritoneal malignancies.

Observation:

  • An 83-year-old male presented with symptoms suggestive of peritoneal disease.
  • Abdominal CT showed heterogeneous peritoneal thickening. 18F-FDG PET/CT revealed low to moderate uptake in thickened areas.
  • 68Ga-FAPI-04 PET/CT demonstrated high uptake in peritoneal and serosal thickening, identifying the malignancy.

Findings:

  • Peritoneal Tru-Cut biopsy confirmed malignant tumoral infiltration consistent with mesothelioma.
  • 68Ga-FAPI-04 PET/CT successfully visualized areas of peritoneal mesothelioma with high radiopharmaceutical uptake.
  • FDG PET/CT showed limited utility in detecting the primary tumor in this case.

Implications:

  • 68Ga-FAPI-04 PET/CT shows potential as a superior imaging agent for evaluating peritoneal mesothelioma.
  • This advanced imaging may improve diagnostic accuracy and guide treatment strategies for peritoneal malignancies.
  • Further research is warranted to establish the role of 68Ga-FAPI-04 PET/CT in clinical practice for mesothelioma.